← Leaderboards
Kameron Azarm
New York University School Of Medicine
$79,893
Attributed
$79,893
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $32.5K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$79,893 · 1
By mechanism
F31$79,893 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Susan Smith$16,159,201
- Devin Michael Bready$142,253
- Gregg L Caporaso$1,054,407
- Agnel Sfeir$14,727,073
Others in their field
Other Emerging Leaders on “Anti-Cancer”
- Leonard Freedman · Leidos Biomedical Research, Inc.$246,654,132
- Lynn Briscoe · Leidos Biomedical Research, Inc.$131,271,272
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$58,795,816
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$50,338,647
- Dwayne Forquer · Leidos Biomedical Research, Inc.$21,434,446
Research focus
Anti-CancerAtrx GeneBaseBindingBiotinCancer CellCancer TherapyCell CycleCell DeathCell DivisionCell GrowthCell ImmortalizationCellsChromatin RemodelingChromosomesCohesinCohesionCoupledEnzymesGenetic RecombinationGenome IntegrityGenome StabilityGenomic InstabilityAlleles
Grant awards (3)
Understanding the role of persistent telomere cohesion in ALT cancer cells$15,319
F31 · FY2020 · CA · contact PI
Understanding the role of persistent telomere cohesion in ALT cancer cells$32,533
F31 · FY2019 · CA · contact PI
Understanding the role of persistent telomere cohesion in ALT cancer cells$32,041
F31 · FY2018 · CA · contact PI